PMC:7696151 / 35963-36216 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1050","span":{"begin":10,"end":13},"obj":"Chemical"},{"id":"1051","span":{"begin":108,"end":111},"obj":"Chemical"}],"attributes":[{"id":"A1050","pred":"tao:has_database_id","subj":"1050","obj":"MESH:D006886"},{"id":"A1051","pred":"tao:has_database_id","subj":"1051","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ated with HCQ than placebo (40.1% vs. 16.8%) [41]. To better assess the incidence of side effects linked to HCQ administration as post-exposure prophylaxis, a cross-sectional study was conducted among 140 doctors. Sixty nine adverse events were document"}

{"project":"LitCovid-sentences","denotations":[{"id":"T237","span":{"begin":51,"end":213},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ated with HCQ than placebo (40.1% vs. 16.8%) [41]. To better assess the incidence of side effects linked to HCQ administration as post-exposure prophylaxis, a cross-sectional study was conducted among 140 doctors. Sixty nine adverse events were document"}